Kezar Life Sciences, Inc. financial data

Symbol
KZR on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 703 % -29.6%
Debt-to-equity 20.78 % +8.5%
Return On Equity -62.53 % -4.7%
Return On Assets -51.77 % -3.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7,323,156 shares +0.37%
Common Stock, Shares, Outstanding 7,323,106 shares +0.37%
Entity Public Float 43,000,000 USD -75.1%
Common Stock, Value, Issued 7,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 7,323,106 shares +0.37%
Weighted Average Number of Shares Outstanding, Diluted 7,323,106 shares +0.37%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 44,707,000 USD -38.2%
General and Administrative Expense 20,811,000 USD -11.8%
Operating Income (Loss) -65,506,000 USD +36.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -61,705,000 USD +35.6%
Earnings Per Share, Basic -8 USD/shares +55.4%
Earnings Per Share, Diluted -8 USD/shares +55.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38,935,000 USD +11.7%
Marketable Securities, Current 51,281,000 USD -54.8%
Accounts Receivable, after Allowance for Credit Loss, Current 7,000,000 USD
Other Assets, Current 935,000 USD +14.3%
Assets, Current 94,501,000 USD -39.6%
Property, Plant and Equipment, Net 2,175,000 USD -30.9%
Operating Lease, Right-of-Use Asset 1,050,000 USD -51%
Other Assets, Noncurrent 0 USD -100%
Assets 97,726,000 USD -40.4%
Accounts Payable, Current 911,000 USD -73.7%
Employee-related Liabilities, Current 2,115,000 USD -0.24%
Accrued Liabilities, Current 3,927,000 USD -59.4%
Liabilities, Current 13,376,000 USD -34.5%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 14,750,000 USD -50.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 14,000 USD -86.9%
Retained Earnings (Accumulated Deficit) -475,986,000 USD -14.9%
Stockholders' Equity Attributable to Parent 82,976,000 USD -38.1%
Liabilities and Equity 97,726,000 USD -40.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17,190,000 USD +24.8%
Net Cash Provided by (Used in) Financing Activities -1,304,000 USD
Net Cash Provided by (Used in) Investing Activities 13,742,000 USD -32.7%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 7,323,106 shares +0.37%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4,747,000 USD -92.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 38,935,000 USD +11.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 189,000 USD -43.8%
Deferred Tax Assets, Valuation Allowance 102,485,000 USD +24.2%
Deferred Tax Assets, Gross 103,144,000 USD +23.1%
Operating Lease, Liability 3,259,000 USD -51%
Depreciation 800,000 USD -33.3%
Payments to Acquire Property, Plant, and Equipment 8,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -61,798,000 USD +34.9%
Lessee, Operating Lease, Liability, to be Paid 3,437,000 USD -53.7%
Property, Plant and Equipment, Gross 9,322,000 USD -0.3%
Operating Lease, Liability, Current 3,259,000 USD -3.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2,418,000 USD -39.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 347,000 USD -91.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 178,000 USD -77.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 347,000 USD -91.5%
Deferred Tax Assets, Operating Loss Carryforwards 50,318,000 USD +17.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits 5,007,000 USD +22.9%
Operating Lease, Payments 3,391,000 USD +17.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 251,000 USD -3.5%
Deferred Tax Assets, Net of Valuation Allowance 659,000 USD -48.4%
Share-based Payment Arrangement, Expense 10,643,000 USD -17.6%
Interest Expense 1,603,000 USD +6.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%